Chronic VEGF Blockade Worsens Glomerular Injury in the Remnant Kidney Model
Carregando...
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2012
Editora
PUBLIC LIBRARY SCIENCE
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
KURIKI, Patricia Semedo
CAMARA, Niels O. S.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
PLOS ONE, v.7, n.6, article ID e39580, 10p, 2012
Resumo
VEGF inhibition can promote renal vascular and parenchymal injury, causing proteinuria, hypertension and thrombotic microangiopathy. The mechanisms underlying these side effects are unclear. We investigated the renal effects of the administration, during 45 days, of sunitinib (Su), a VEGF receptor inhibitor, to rats with 5/6 renal ablation (Nx). Adult male Munich-Wistar rats were distributed among groups S+V, sham-operated rats receiving vehicle only; S+Su, S rats given Su, 4 mg/kg/day; Nx+V, Nx rats receiving V; and Nx+Su, Nx rats receiving Su. Su caused no change in Group S. Seven and 45 days after renal ablation, renal cortical interstitium was expanded, in association with rarefaction of peritubular capillaries. Su did not worsen hypertension, proteinuria or interstitial expansion, nor did it affect capillary rarefaction, suggesting little angiogenic activity in this model. Nx animals exhibited glomerulosclerosis (GS), which was aggravated by Su. This effect could not be explained by podocyte damage, nor could it be ascribed to tuft hypertrophy or hyperplasia. GS may have derived from organization of capillary microthrombi, frequently observed in Group Nx+Su. Treatment with Su did not reduce the fractional glomerular endothelial area, suggesting functional rather than structural cell injury. Chronic VEGF inhibition has little effect on normal rats, but can affect glomerular endothelium when renal damage is already present.
Palavras-chave
Referências
- Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663
- ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013
- Bollee G, 2009, NEPHROL DIAL TRANSPL, V24, P682, DOI 10.1093/ndt/gfn657
- BROWN LF, 1992, KIDNEY INT, V42, P1457, DOI 10.1038/ki.1992.441
- Costero O, 2010, NEPHROL DIAL TRANSPL, V25, P1001, DOI 10.1093/ndt/gfp666
- Eardley KS, 2008, KIDNEY INT, V74, P495, DOI 10.1038/ki.2008.183
- Eckardt Kai-Uwe, 2005, Kidney Int Suppl, pS46
- El Awad B, 2000, KIDNEY INT, V58, P43, DOI 10.1046/j.1523-1755.2000.00139.x
- Eremina V, 2010, SEMIN NEPHROL, V30, P582, DOI 10.1016/j.semnephrol.2010.09.006
- Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330
- Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798
- FLOEGE J, 1992, KIDNEY INT, V41, P297, DOI 10.1038/ki.1992.42
- Flyvbjerg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE362, DOI 10.1152/ajpendo.00007.2002
- Foster RR, 2003, AM J PHYSIOL-RENAL, V284, pF1263, DOI 10.1152/ajprenal.00276.2002
- Fujihara CK, 1998, KIDNEY INT, V54, P1510, DOI 10.1046/j.1523-1755.1998.00138.x
- Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF1810, DOI 10.1152/ajprenal.00521.2006
- Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313
- Gkountouvas A, 2010, THYROID, V20, P597, DOI 10.1089/thy.2010.0028
- Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005
- HIROSE K, 1982, KIDNEY INT, V21, P689, DOI 10.1038/ki.1982.82
- ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874
- Izzedine H, 2007, AM J KIDNEY DIS, V50, P203, DOI 10.1053/j.ajkd.2007.04.025
- Izzedine H, 2007, CANCER CHEMOTH PHARM, V60, P357, DOI 10.1007/s00280-006-0376-5
- Izzedine H, 2010, EUR J CANCER, V46, P439, DOI 10.1016/j.ejca.2009.11.001
- JEPSEN FL, 1979, VIRCHOWS ARCH A, V383, P265, DOI 10.1007/BF00430245
- Kang DH, 2001, J AM SOC NEPHROL, V12, P1434
- Kappers MHW, 2009, J HYPERTENS, V27, P2297, DOI 10.1097/HJH.0b013e3283309b59
- Kappers MHW, 2010, HYPERTENSION, V56, P675, DOI 10.1161/HYPERTENSIONAHA.109.149690
- KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
- Kelly DJ, 2003, NEPHROL DIAL TRANSPL, V18, P1286, DOI 10.1093/ndt/gfg176
- Kretzler M, 1998, Kidney Int Suppl, V67, pS159
- Kubo H, 2003, GENE DEV, V17, P322, DOI 10.1101/gad.1071203
- LAX DS, 1992, KIDNEY INT, V41, P1527, DOI 10.1038/ki.1992.222
- LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
- Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10
- Mendel DB, 2003, CLIN CANCER RES, V9, P327
- Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124
- Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044
- NAGATA M, 1992, KIDNEY INT, V42, P148, DOI 10.1038/ki.1992.272
- Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
- PLOUET J, 1989, EMBO J, V8, P3801
- Rodriguez-Iturbe B, 2002, AM J PHYSIOL-RENAL, V282, pF191
- Schatteman GC, 2004, ANAT REC PART A, V276A, P13, DOI 10.1002/ar.a.10131
- Schrijvers BF, 2004, KIDNEY INT, V65, P2003, DOI 10.1111/j.1523-1755.2004.00621.x
- Schrijvers BF, 2005, NEPHRON EXP NEPHROL, V101, pE9, DOI 10.1159/000086034
- SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562
- Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295
- Spyridopoulos I, 1997, J MOL CELL CARDIOL, V29, P1321, DOI 10.1006/jmcc.1996.0365
- Tanaka T, 2010, CURR OPIN NEPHROL HY, V19, P43, DOI 10.1097/MNH.0b013e3283328eed
- WALLENSTEIN S, 1980, CIRC RES, V47, P1
- Wu QQ, 2006, AM J NEPHROL, V26, P97, DOI 10.1159/000092032
- Yang NS, 1998, NEPHROL DIAL TRANSPL, V13, P1967, DOI 10.1093/ndt/13.8.1967
- Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159